There is a growing interest in microdosing GLP-1 drugs, including semaglutide, for weight loss, with some outlets exploring their effectiveness. However, not all medical professionals agree that microdosing these medications is a good idea, citing potential concerns. The safety and efficacy of GLP-1 microdosing for weight loss and other potential benefits, such as longevity, are being questioned and debated by various health organizations.